None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. A case of mantle cell lymphoma newly diagnosed by a pathologist (based on the classification criteria of WHO revised in 2016) 1) mantle cell lymphoma 2) leukemic nonnodal mantle cell lymphoma 3) in situ mantle cell neoplasia 2. 19 years or older 3. Patients signed informed consent form
Exclusion criteria
Exclusion criteria: 1. Lymphoma subtypes except the Inclusion criteria (based on the classification criteria of WHO revised in 2016) 2. Patients who do not understand or agree to the written Informed consent form 3. Patients who have a malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Primary treatment overall response rate;Salvage treatment overall response rate;Progression free survival | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center